Three-year follow-up of bladder tumours found on screening.
The clinical course, over a period of 3 years, of 17 bladder tumours found on screening a male population (2356 individuals) aged over 60, is reported. Even with this relatively small population, the importance of distinguishing pathologically between a pTa and a pT1 tumour is emphasised. The progression rate to date of pT1 tumours (1 of 9: 11%) is significantly less than that reported in larger studies on symptomatic patients. The simplicity of this screening process, together with the ease of out-patient investigation (combining ultrasound, flexible cystoscopy and urine cytology) indicate the need for a comprehensive prospective randomised trial to test the efficacy of screening for bladder tumours in populations who are known to be at risk.
Whelan
P
P
Department of Urology, St. James's University Hospital NHS Trust, Leeds.
Britton
J P
JP
Dowell
A C
AC
D000368:Aged; D005500:Follow-Up Studies; D006417:Hematuria / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011934:Reagent Strips; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000150:complications / Q000453:epidemiology* / Q000473:pathology
D011934:Reagent Strips